Trial Profile
A Dose-escalation Study to Assess the Feasibility and Safety of 3 Different Doses of NeoFuse When Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion With Instrumentation
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Jun 2020
Price :
$35
*
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Intervertebral disc degeneration; Intervertebral disc displacement; Spinal stenosis
- Focus Adverse reactions; First in man
- Sponsors Mesoblast
- 18 Sep 2014 New trial record